The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist
Abstract
PURPOSE: The cost implications of and potential adverse events prevented by the interventions of a critical care pharmacist were studied. METHODS: A decentralized clinical pharmacist assigned to a surgical intensive care unit (ICU) documented all interventions made from mid-October 2003 through February 2004 using a standardized written form. The data were retrospectively evaluated and the following information was extracted: amount of time spent performing various clinical activities, how drug-related problems were identified (e.g., order entry versus chart review), and a general description of the interventions. The interventions were independently reviewed by two other clinical pharmacists to determine whether an actual or potential adverse drug event (ADE) would have occurred without the intervention, the probability that an ADE would have occurred without the intervention, the type of intervention, and potential cost avoidance of the intervention. Once the evaluations were completed, the data obtained from order entry and verification activities were compared with the data obtained during other clinical functions. RESULTS: A total of 129 interventions were documented over 4.5 months. The majority of interventions were identified during chart review (40%) and patient care rounds (39%). The potential cost avoidance of the documented interventions was $205,919-$280,421. Interventions identified during patient care rounds and chart review were most likely to achieve the greatest impact on cost avoidance. CONCLUSION: Among the interventions performed and documented by a clinical pharmacist in an ICU, patient care rounds and chart-review activities were associated with the greatest number of interventions and the greatest potential cost avoidance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Byrt, T., Bishop, J., & Carlin, J. B. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90018-v · Cited by 2,179
High agreement but low kappa: II. Resolving the paradoxes
Cicchetti, D. V., & Feinstein, A. R. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90159-m · Cited by 1,838
Cited by
Role of the pharmacist in reducing healthcare costs: current insights
Dalton, K., & Byrne, S. (2017) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s108047 · Cited by 449
Metadata
- Authors
- Kopp, B. J., Mrsan, M., Erstad, B. L., & Duby, J. J.
- Venue
- American Journal of Health-System Pharmacy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-01
- Volume
- 64
- Issue
- 23
- Pages
- 2483-2487
- ISSN
- 1079-2082 (ISSN-L)
- 1535-2900
- OpenAlex
- W2145469316
- Cited by
- 196
- References
- 2
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. https://app.cochat.ai/papers/10.2146/ajhp060674
- The paper
- Kopp, B. J., Mrsan, M., Erstad, B. L., & Duby, J. J. (2007). Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. American Journal of Health-System Pharmacy. https://doi.org/10.2146/ajhp060674
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.